CORRECTED-UPDATE 1-Takeda, Lilly lose bid to overturn $9 bln award for hiding cancer risk

(Corrects number of decisions in Actos lawsuits from three to six in final paragraph)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.